Market Overview:
The global 2019-nCoV Test Suite market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory diseases, growing demand for point-of-care diagnostics, and rising awareness about advanced diagnostic techniques. Based on type, the global 2019-nCoV Test Suite market is segmented into fluorescent PCR and colloidal gold. The fluorescent PCR segment is expected to grow at a higher CAGR than the colloidal gold segment during the forecast period. This can be attributed to its advantages such as high sensitivity and specificity, ability to detect low viral loads, and short turnaround time. Based on application, the global 2019-nCoV Test Suite market is divided into hospital laboratories, government laboratories/institutes, commercial laboratories/private clinics/hospitals), and other end users (academic research institutes). The hospital laboratories segment accounted for majority of share in 2017 owing to increasing number of hospitals worldwide coupled with rising demand for advanced diagnostic tests for detection of various respiratory viruses including 2019-nCoV virus.
Product Definition:
The 2019-nCoV Test Suite is a set of tests that can be used to determine whether a system is infected with the 2019-nCoV virus. The tests can be used to help identify and isolate infected systems, and to help prevent the spread of the virus.
Fluorescent PCR:
Fluorescent Polymerase Chain Reaction (PCR) is a technique that uses fluorescent dyes to detect and measure genetic material. It works by enhancing the ability of DNA polymerase to synthesize a new stretch of DNA from start to finish in only 30 minutes. This process is called as PCR amplification, which can be used for both positive and negative samples.
Colloidal Gold:
Colloidal gold is a nanocoatrined liquid that has been used as an antimicrobial coating in medical devices and surgical instruments for decades. It is also known as colloidal hydrophobic gold, or sometimes colloidal antibiotic. The nCoV test suite uses this technology to ensure the safety of healthcare workers by detecting the presence of harmful pathogens in their body fluids such as blood, urine, sweat & saliva.
Application Insights:
The others application segment accounted for the largest revenue share in 2017 and is anticipated to witness significant growth over the forecast period. The others application segment includes clinical trials, coronavirus-related research, and surveillance. The hospital application segment is expected to be one of the fastest-growing segments during the forecast period owing to a rise in number of patients with respiratory symptoms across the globe. As per WHO, around 35% of people with COVID-19 have reported mild or no symptoms thus far which has led to an increase in demand for diagnostic tests at a global level as well as within each country.
Infectious diseases are one of the major causes of death worldwide; therefore control measures taken against them should not result in any loss whatsoever on account of business interruptions or other such disadvantages that may be caused due to restriction on movement etc.
Regional Analysis:
North America dominated the market in terms of revenue share in 2019. The growth is attributed to the increasing COVID-19 cases and high adoption rate of this technology across various research laboratories. In addition, presence of key players such as Roche Diagnostics Corporation; Abbott Laboratories; Bio-Rad Laboratories, Inc.; and American Type Culture Collection (ATCC) that are engaged in continuous efforts for development and commercialization of COVID-19 tests will drive regional demand over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising government initiatives for implementation of advanced technologies across emerging countries such as India and China along with Japan. For instance, Ministry Of Health Labor And Welfare (MoHW) Of Japan has developed a new diagnostic test based on real-time PCR that can be used for rapid diagnosis at community level which will further boost regional demand during the forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for quality and compliance testing services
- Growing number of nCoV outbreaks and the need for timely detection and containment
- Proliferation of digital health solutions and the need for nCoV Test Suite validation
- Increased funding for R&D in life sciences sector
- Rising awareness about the benefits of early nCoV Test Suite adoption
Scope Of The Report
Report Attributes
Report Details
Report Title
2019-nCoV Test Suite Market Research Report
By Type
Fluorescent PCR, Colloidal Gold
By Application
Hospital, Government, Others
By Companies
Sansure, Life River, Haitai, Da An Gene, BGI, Bio-Germ, GENEODX, Maccura Biotechnology, Wondfo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global 2019-nCoV Test Suite Market Report Segments:
The global 2019-nCoV Test Suite market is segmented on the basis of:
Types
Fluorescent PCR, Colloidal Gold
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Government, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sansure
- Life River
- Haitai
- Da An Gene
- BGI
- Bio-Germ
- GENEODX
- Maccura Biotechnology
- Wondfo
Highlights of The 2019-nCoV Test Suite Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluorescent PCR
- Colloidal Gold
- By Application:
- Hospital
- Government
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 2019-nCoV Test Suite Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The 2019-nCoV Test Suite is a collection of tools and scripts to help you test your network security products. It includes tests for various protocols, vulnerabilities, and attack vectors.
Some of the major players in the 2019-ncov test suite market are Sansure, Life River, Haitai, Da An Gene, BGI, Bio-Germ, GENEODX, Maccura Biotechnology, Wondfo.
The 2019-ncov test suite market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 2019-nCoV Test Suite Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 2019-nCoV Test Suite Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 2019-nCoV Test Suite Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 2019-nCoV Test Suite Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 2019-nCoV Test Suite Market Size & Forecast, 2020-2028
4.5.1 2019-nCoV Test Suite Market Size and Y-o-Y Growth
4.5.2 2019-nCoV Test Suite Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Fluorescent PCR
5.2.2 Colloidal Gold
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Government
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 2019-nCoV Test Suite Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 2019-nCoV Test Suite Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Fluorescent PCR
9.6.2 Colloidal Gold
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Government
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Fluorescent PCR
10.6.2 Colloidal Gold
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Government
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Fluorescent PCR
11.6.2 Colloidal Gold
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Government
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Fluorescent PCR
12.6.2 Colloidal Gold
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Government
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Fluorescent PCR
13.6.2 Colloidal Gold
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Government
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 2019-nCoV Test Suite Market: Competitive Dashboard
14.2 Global 2019-nCoV Test Suite Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sansure
14.3.2 Life River
14.3.3 Haitai
14.3.4 Da An Gene
14.3.5 BGI
14.3.6 Bio-Germ
14.3.7 GENEODX
14.3.8 Maccura Biotechnology
14.3.9 Wondfo
